Barclays
AMTI

Barclays’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Barclays’s Portfolio AMTI Stock Details AMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,154
Closed -$2.62K – 4755
2023
Q2 		$2.62K Hold
10,154
– – ﹤0.01% 4308
2023
Q1 		$3.25K Hold
10,154
– – ﹤0.01% 4861
2022
Q4 		$4.26K Hold
10,154
– – ﹤0.01% 5015
2022
Q3 		$10K Hold
10,154
– – ﹤0.01% 4328
2022
Q2 		$30K Sell
10,154
-4,115
-29% -$17.3K ﹤0.01% 4252
2022
Q1 		$106K Buy
+14,269
New +$118K ﹤0.01% 3755

Other funds holding AMTI

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Barclays's AMTI Position: Q3 2023 in Review

Barclays sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q3 2023, closing a stake of 10,154 shares — an estimated $2.62K sold.

Barclays first reported a position in AMTI in Q1 2022 and held it in 6 quarters. The position peaked at $106K in Q1 2022. 27 funds tracked by Wall St. Rank hold AMTI as of Q3 2023.

  • Barclays reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Barclays sold 10,154 Applied Molecular Transport Inc. Common Stock shares in Q3 2023, an estimated $2.62K.
  • Barclays first reported a position in Applied Molecular Transport Inc. Common Stock in Q1 2022 and held it in 6 quarters.
  • Barclays's Applied Molecular Transport Inc. Common Stock position peaked at $106K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q3 2023.

Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.